A group of investors suggested reverse mergers, licensing strategies and oncology companies during a panel on how to fund a startup company in biotech or medtech. One investor said four forces were combining to make 2013 a great year for medtech.
Venture capital investment in the life sciences has fallen 39 percent over the past three years as the costly, lengthy process of getting approval for pharmaceuticals from the Food and Drug Administration has spurred companies to shift their investments to overseas markets in Europe and Asia. According to the survey of 150 venture capital firms, […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.